This site is intended for healthcare professionals
Micrograph of bone marrow rendered in pinks and purples

Find disease awareness content and relevant supporting materials

    Learning Zone CME Events News Trials Guidelines Journals
    Filter results
    Sort by:
    Relevance
    to
    Blue test tubes arranged in a line, disappearing into the background
    Drug news
    20/06/14

    Phase III trials of Movantik for OIC published in NEJM-AstraZeneca

    AstraZeneca has announced that the New England Journal of Medicine has published results of two pivotal Phase III studies �...

    Blue test tubes arranged in a line, disappearing into the background
    Drug news
    14/11/12

    Positive results in Phase III trials of Naloxegol (AstraZeneca) for patients with Opioid Induced Constipation

    Two Phase III trials and one safety extension trial of Naloxegol (naxolol), from AstraZeneca, in patients with non-cancer related pain...

    Blue test tubes arranged in a line, disappearing into the background
    Drug news
    27/02/13

    Phase III trial of Naloxegol (AstraZeneca) confirms earlier safety studies in patients with Opioid-induced Constipation

    New results from KODIAC-08, an open-label, randomised, 52-week, long-term safety trial of Naloxegol (naxolol), from AstraZeneca, in patients with non-cancer...

    Blue test tubes arranged in a line, disappearing into the background
    Drug news
    16/05/15

    Analysis of Phase III trial of Movantik (naloxegol) in Opioid Constipation-AstraZeneca

    Further analysis of the Phase III KODIAC-04, KODIAC-05 and KODIAC-08 studies showed that Movantik (naloxegol), from AstraZeneca, had a similar...

    Blue test tubes arranged in a line, disappearing into the background
    Drug news
    23/07/15

    NICE recommends Moventig (naloxegol) for treatment of opioid-induced constipation- AstraZeneca

    The National Institute for Health and Care Excellence (NICE) in new final guidelines has recommended Moventig (naloxegol) from AstraZeneca as...

    Blue test tubes arranged in a line, disappearing into the background
    Drug news
    19/09/13

    Naloxegol filed with the FDA for Opioid Constipation

    AstraZeneca has filed a new drug submission with the FDA for Naloxegol (naxolol), for the treatment of Opioid induced Constipation....

    Blue test tubes arranged in a line, disappearing into the background
    Drug news
    20/03/15

    Astra Zeneca will co market Movantik (naloxegol) in the US with Daiichi Sankyo.

    AstraZeneca announced a co-commercialisation agreement with Daiichi Sankyo, Inc. for Movantik (naloxegol) in the USA. Under the terms of the...

    Blue test tubes arranged in a line, disappearing into the background
    Drug news
    16/09/14

    FDA approves Movantik for treatment of Opioid-Induced Constipation in patients with Chronic Non Cancer Pain. - AstraZeneca

    AstraZeneca has announced that the FDA approved Movantik (naloxegol) tablets C-II as the first once-daily oral peripherally-acting mu-opioid receptor antagonist...

    Blue test tubes arranged in a line, disappearing into the background
    Drug news
    10/12/14

    EU approves Moventig for Opioid-induced Constipation- AstraZeneca

    AstraZeneca has announced that Moventig (naloxegol) has been granted Marketing Authorisation by the European Commission (EC) for the treatment of...

    Blue test tubes arranged in a line, disappearing into the background
    Drug news
    02/03/16

    ProStrakan/Kyowa Hakko Kirin to market Moventig (naloxegol) to treat opioid-induced constipation in the EU- AstraZeneca

    AstraZeneca announced that it has entered into an agreement with ProStrakan Group, a subsidiary of Kyowa Hakko Kirin Co. Ltd.,...

    See more